KemNet supplies pharmacies with premium reformulations of popular drugs that are more useful for specific groups of patients. For example, more than 30 pharmacies rely on KemNet to supply reformulated products for erectile dysfunction that work up to 8 times faster than alternatives.
KemNet is a Y Combinator company in the Summer 2022 batch. Its directory entry describes it as: KemNet supplies reformulated drugs for specific groups of patients. The founder listed is Morẹ́nikẹ́ Ọláòṣebìkan (Founder) (Y Combinator directory entry, August 8, 2022).
Sell to companies like KemNet? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2022-08-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns KemNet.
Free to see. No signup.
More on KemNet and the records around it.
Same batch, Healthcare first.
Get an email when KemNet changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when KemNet raises, hires or launches. No email unless you switch it on.
Watch KemNet →Get the full cited report on KemNet
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on KemNet: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
KemNet supplies pharmacies with premium reformulations of popular drugs that are more useful for specific groups of patients. For example, more than 30 pharmacies rely on KemNet to supply reformulated products for erectile dysfunction that work up to 8 times faster than alternatives. In addition to sexual function, products reformulated for novel drug delivery and supplied on KemNet include medications for hair growth, pain, weight loss and women's health.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on KemNet: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on KemNet covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist KemNetYou get an alert in MentionFox the next time this company shows up.
If you're behind KemNet: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for KemNet. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-kemnet